PROCTER AND GAMBLE FDA Approval NDA 012402

NDA 012402

PROCTER AND GAMBLE

FDA Drug Application

Application #012402

Application Sponsors

NDA 012402PROCTER AND GAMBLE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 180MG BASE/VIAL0IVADANTINNITROFURANTOIN SODIUM

FDA Submissions

TYPE 2; Type 2 - New Active IngredientORIG1AP1960-09-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1979-06-06STANDARD
LABELING; LabelingSUPPL16AP1979-06-06STANDARD
LABELING; LabelingSUPPL17AP1979-07-13STANDARD
LABELING; LabelingSUPPL19AP1982-10-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1982-04-13STANDARD

Submissions Property Types

ORIG1Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL19Null0
SUPPL21Null0

CDER Filings

PROCTER AND GAMBLE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 12402
            [companyName] => PROCTER AND GAMBLE
            [docInserts] => ["",""]
            [products] => [{"drugName":"IVADANTIN","activeIngredients":"NITROFURANTOIN SODIUM","strength":"EQ 180MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"IVADANTIN","submission":"NITROFURANTOIN SODIUM","actionType":"EQ 180MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.